In vivo and in vitro characterisation of a nonpeptide vasopressin V1A and V2 receptor antagonist (YM087) in the rat

Hormonal Stimulation of Phosphatidylinositol Breakdown, with Particular Reference to the Hepatic Effects of Vasopressin

Robert H. Michell, Christopher J. Kirk, M. M. BILLAH · Biochemical Society Transactions · 1979 · 436 citations

Life Sciences, Biochemistry, Physiology +8

Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.

Toru Sugimoto, Masayuki Saito, Shinobu Mochizuki et al. · Journal of Biological Chemistry · 1994 · 373 citations · Full text

Life Sciences, Molecular Biology, Physiology +15

Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V₂ receptor antagonist

Yoshitaka Yamamura, Hidenori Ogawa, Hiroshi Yamashita et al. · British Journal of Pharmacology · 1992 · 347 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats

Yoshitaka Yamamura, Shigeki Nakamura, S. Itoh et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 332 citations · Full text

Medicine, Pharmacology, Molecular Pharmacology +12

Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.

Serge Jard, Rolf C. Gaillard, Gilles Guillon et al. · Molecular Pharmacology · 1986 · 273 citations

Life Sciences, Pharmacology, Physiology +15